Publication

Plasmonic-enhancement of vibrational circular dichroism in plasmonic nanostructures embedding chiral drugs

2025

Abstract

We investigate the mid-infrared chiroptical response of Aluminum-doped Zinc Oxide (AZO)-based plasmonic nanostructures incorporating pharmaceutical chiral drug solutions. We systematically examine plasmon-enhanced vibrational circular dichroism (VCD) of the chiral drug solution to develop efficient chiroptical sensing techniques.

Official source

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

2025

Abstract

Official source

Related concepts (16)

Chirality (chemistry)

In chemistry, a molecule or ion is called chiral (ˈkaɪrəl) if it cannot be superposed on its by any combination of rotations, translations, and some conformational changes. This geometric property is called chirality (kaɪˈrælɪti). The terms are derived from Ancient Greek χείρ (cheir) 'hand'; which is the canonical example of an object with this property. A chiral molecule or ion exists in two stereoisomers that are mirror images of each other, called enantiomers; they are often distinguished as either "right-handed" or "left-handed" by their absolute configuration or some other criterion.

Chiral resolution

Chiral resolution, or enantiomeric resolution, is a process in stereochemistry for the separation of racemic compounds into their enantiomers. It is an important tool in the production of optically active compounds, including drugs. Another term with the same meaning is optical resolution. The use of chiral resolution to obtain enantiomerically pure compounds has the disadvantage of necessarily discarding at least half of the starting racemic mixture. Asymmetric synthesis of one of the enantiomers is one means of avoiding this waste.

Chiral switch

A chiral switch is a chiral drug that has already approved as racemate but has been re-developed as a single enantiomer. The term chiral switching was introduced by Agranat and Caner in 1999 to describe the development of single enantiomers from racemate drugs. For example, levofloxacin is a chiral switch of racemic ofloxacin. The essential principle of a chiral switch is that there is a change in the status of chirality. In general, the term chiral switch is preferred over racemic switch because the switch is usually happening from a racemic drug to the corresponding single enantiomer(s).

Related publications (4)

Plasmonic-enhancement of vibrational circular dichroism in plasmonic nanostructures embedding chiral drugs

Chat with Graph Search

Asymmetric Bio- and Organocatalysis: Historical Aspects and Concepts

Asymmetric Phase-Transfer-Catalyzed Intramolecular N-Alkylation of Indoles and Pyrroles: A Combined Experimental and Theoretical Investigation

Mechanical integrity of transparent conductive oxide films for flexible polymer-based displays